All Stories

  1. Randomized controlled trials and alternative study designs in surgical oncology
  2. Electromotive Enhanced Drug Administration in Oncology: Principles, Evidence, Current and Emerging Applications
  3. Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
  4. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
  5. The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study
  6. Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling
  7. Incidence of lymph node recurrence after primary surgery for non-metastatic colon cancer: A systematic review
  8. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer
  9. Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  10. Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative
  11. Patient‐reported outcomes after pelvic exenteration for colorectal cancer: A systematic review
  12. Biomechanical aspects of the normal and cancer-associated lymphatic system
  13. Anatomical and temporal patterns of lymph node metastasis in colorectal cancer
  14. Primary and metastatic peritoneal surface malignancies
  15. Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery
  16. The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
  17. Optimization of Intraperitoneal Aerosolized Drug Delivery: A Computational Fluid Dynamics (CFD) and Experimental Study
  18. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
  19. Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols
  20. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
  21. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
  22. Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
  23. Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei: diagnostic and therapeutic algorithms based on current evidence
  24. Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases: A first in human phase I study.
  25. Intraperitoneal EpCAM-Targeted Immunotoxin: A First Step Towards Engineering the Immune Environment in Colorectal Peritoneal Metastases?
  26. Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
  27. Pressurized intraperitoneal aerosol chemotherapy in peritoneal carcinomatosis: is it all up in the air?
  28. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
  29. Trace amounts of irinotecan found in the blood of a surgeon after performing HIPEC: what does it imply?
  30. The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer
  31. Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey
  32. Impact of low anterior resection syndrome (LARS) on the quality of life and treatment options of LARS – A cross sectional study
  33. Society of Surgical Oncology SSO 2021 – International Conference on Surgical Cancer Care
  34. Debulking and HIPEC for ovarian cancer: effects of perfusion temperature on morbidity and cisplatin pharmacokinetics
  35. Electrostatic precipitation pressurized intraperitoneal aerosol chemotherapy (ePIPAC): Finding the optimal electrical potential
  36. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)
  37. Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?
  38. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma
  39. PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy
  40. Synergy between Intraperitoneal Aerosolization (PIPAC) and Cancer Nanomedicine: Cisplatin-Loaded Polyarginine-Hyaluronic Acid Nanocarriers Efficiently Eradicate Peritoneal Metastasis of Advanced Human Ovarian Cancer
  41. Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion
  42. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
  43. Heating technology for malignant tumors: a review
  44. Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook
  45. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review
  46. Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma
  47. Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis
  48. A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
  49. A practical risk scale for predicting morbidity and mortality in the emergency general surgical setting: A prospective multi-center study
  50. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study
  51. HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
  52. Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis
  53. Assessment of graft perfusion and oxygenation for improved outcome in esophageal cancer surgery
  54. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups
  55. Anorectal symptoms during pregnancy and postpartum: a prospective cohort study
  56. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
  57. Pharmacokinetics and Tissue Transport of Intraperitoneal Chemotherapy
  58. Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis – a phase I first-in-human study
  59. The impact of surgical resection of the primary tumor on the development of synchronous colorectal liver metastasis: a systematic review
  60. Intraoperative radiation therapy for rectal cancer and recurrent intra-abdominal sarcomas
  61. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE
  62. Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
  63. Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo
  64. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
  65. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study
  66. Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer
  67. Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation
  68. Adipose-Derived Mesenchymal Stromal Cells Improve the Healing of Colonic Anastomoses Following High Dose of Irradiation Through Anti-Inflammatory and Angiogenic Processes
  69. Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle
  70. Tumour tissue transport after intraperitoneal anticancer drug delivery
  71. Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer
  72. High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes
  73. Frailty as a predictor of mortality in the elderly emergency general surgery patient
  74. Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule
  75. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  76. Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection
  77. Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis — Mission possible?
  78. The VEGFR Inhibitor Cediranib Improves the Efficacy of Fractionated Radiotherapy in a Colorectal Cancer Xenograft Model
  79. Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer
  80. The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score
  81. Age and cellular context influence rectal prolapse formation in mice with caecal wall colorectal cancer xenografts
  82. Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid
  83. Preclinical activity of melflufen (J1) in ovarian cancer
  84. Assessment of Ovarian Cancer Tumors Treated with Intraperitoneal Cisplatin Therapy by Nanoscopic X-ray Fluorescence Imaging
  85. Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization
  86. Metabolic surgery in patients over 60 years old: short- and long-term results
  87. Data on in vivo selection of SK-OV-3 Luc ovarian cancer cells and intraperitoneal tumor formation with low inoculation numbers
  88. Lifelike Vascular Reperfusion of a Thiel-Embalmed Pig Model and Evaluation as a Surgical Training Tool
  89. Animal models of colorectal peritoneal metastasis
  90. Scoring histological regression in peritoneal carcinomatosis: does it count?
  91. BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis
  92. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei
  93. Colloidal stability of nano-sized particles in the peritoneal fluid: Towards optimizing drug delivery systems for intraperitoneal therapy
  94. Recent insights into the pathophysiology of omental metastases
  95. Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery
  96. A Model Based Analysis of IPEC Dosing of Paclitaxel in Rats
  97. Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis
  98. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon
  99. Surgery, wound healing, and metastasis: Recent insights and clinical implications
  100. Clinical Research in Surgery: Threats and Opportunities
  101. Postmortem Pump-Driven Reperfusion of the Vascular System of Porcine Lungs: Towards a New Model for Surgical Training
  102. Molecular Imaging of Tumor-Associated Angiogenesis Using a Novel Magnetic Resonance Imaging Contrast Agent Targeting αvβ3 Integrin
  103. Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: Review of animal models
  104. Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin
  105. Recommendations for reporting outcome results in abdominal wall repair
  106. Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
  107. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
  108. Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
  109. Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members
  110. Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  111. Endovascular Treatment of an Iatrogenic Perforation of the Internal Iliac Vein
  112. Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project
  113. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
  114. Development of a Nanocrystalline Paclitaxel Formulation for Hipec Treatment
  115. Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project
  116. Magnetic Electrospun Fibers for Cancer Therapy
  117. The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study
  118. Anastomotic Complications After Ivor Lewis Esophagectomy in Patients Treated With Neoadjuvant Chemoradiation Are Related to Radiation Dose to the Gastric Fundus
  119. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis
  120. Use of pneumatic nebulization and laser ablation–inductively coupled plasma–mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug
  121. Innovation in Cancer Imaging
  122. Progress in Rectal Cancer Treatment
  123. Variability of CT Contrast Enhancement in the Pancreas: A Cause for Concern?
  124. Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography
  125. Flip angle optimization for dynamic contrast-enhanced MRI-studies with spoiled gradient echo pulse sequences
  126. First order correction for T2*-relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity
  127. Assessment of Tumor Vascularization in Pancreatic Adenocarcinoma Using 128-Slice Perfusion Computed Tomography Imaging
  128. Malignant Peritoneal Mesothelioma in a Patient With Li-Fraumeni Syndrome
  129. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
  130. Antitumour Efficacy of Two Paclitaxel Formulations for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in an In Vivo Rat Model
  131. Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI
  132. Noninvasive Monitoring of Therapy-Induced Microvascular Changes in a Pancreatic Cancer Model Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging with P846, a New Low-Diffusible Gadolinium-Based Contrast Agent
  133. Long-Term Results of a Prospective Study on Laparoscopic Adjustable Gastric Banding for Morbid Obesity
  134. Conversion from Band to Bypass in Two Steps Reduces the Risk for Anastomotic Strictures
  135. Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic Review
  136. Laparoendoscopic Single-Site Gastrectomy for a Gastric GIST Using Double-Bended Instruments
  137. In vivo Toxicity and Bioavailability of Taxol® and a Paclitaxel/β-Cyclodextrin Formulation in a Rat Model During HIPEC
  138. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
  139. Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion in Women with Heavily Pretreated Recurrent Ovarian Cancer
  140. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence
  141. Letter 1: Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer (Br J Surg2009; 96: 982-989)
  142. Combined Effect of EPO and Radiotherapy on the Expression of Endogenous Molecular Markers of Tumor Metabolism and Metastasis
  143. An Unusual Post Gastrectomy Complication
  144. Preoperative chemoradiationversusradiation alone for stage II and III resectable rectal cancer: A systematic review and meta-analysis
  145. Total vs Partial Fundoplication in the Treatment of Gastroesophageal Reflux Disease
  146. In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC
  147. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
  148. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment
  149. Attempted Suicide by Auto-Injection of Polyurethane (PU) Foam: Report of a Case
  150. Therapeutic Decision-Making in Endoscopically Unmanageable Nonvariceal Upper Gastrointestinal Hemorrhage
  151. Use of Laparoscopy for Rectal Cancer: A Word of Caution
  152. Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis
  153. Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion – Formulation and stability
  154. Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
  155. Neoadjuvant Chemoradiation Versus Hyperfractionated Accelerated Radiotherapy in Locally Advanced Rectal Cancer
  156. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
  157. Pre-operative combined modality therapy in the management of locally advanced rectal cancer
  158. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
  159. Prospectively Randomized Trial Using Perioperative Low-dose Octreotide to Prevent Organ-related and General Complications after Pancreatic Surgery and Pancreatico-jejunostomy
  160. One- to Three-Year Results of Gastric Banding on Secondary Complications of Morbid Obesity in 625 Patients
  161. Functional Outcome Following Colon Interposition in Total Pharyngoesophagectomy with or without Laryngectomy
  162. The beneficial effects of supplementary glutamine on experimental irradiated colonic anastomosis; histological and morphological evaluation
  163. Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band
  164. Determination of the K adsorption site on Fe() with XSW
  165. Influence of preoperative combined radiochemotherapy on surgical outcome and colonic anastomotic healing: experimental study in the rat
  166. The Swedish Laparoscopic Adjustable Gastric Banding for Morbid Obesity
  167. Influence of preoperative high-dose radiotherapy on postoperative outcome and colonic anastomotic healing
  168. Healing of experimental colonic anastomoses: Effects of combined preoperative high-dose radiotherapy and intraperitoneal 5-fluorouracil
  169. Authors' reply
  170. Das anpassbare Silicon Gastric Banding (ASGB, Bioenterics®) und das Schwedische anpassbare Gastric Banding (SAGB, Obtech®) zur Behandlung der morbiden Obesitas
  171. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer
  172. Morphology and composition of Au films on Si(100)
  173. Surgeons and the Internet
  174. Ultrathin Au layers on Si(100): surface silicide formation at room temperature
  175. Domain structure, segregation and morphology of the Pt3Sn(111) surface
  176. K adsorption on Fe(100) studied by X-ray standing waves
  177. Non-operative management of a splenic laceration in a patient with the Proteus syndrome.
  178. Substitutional adsorption of K on Fe(100)
  179. Caesium diffusion in sodium borosilicate glass studied by low-energy ion scattering